Cargando…

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters

BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Mariam, Mahmood, Fareeha, Mata, Mariana, Durkin, Helen G, Liu, Chenglong, Greenblatt, Ruth M, Nowicki, Marek, Golub, Elizabeth T, Anastos, Kathryn, French, Audrey L, Baum, Linda L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718584/
https://www.ncbi.nlm.nih.gov/pubmed/26798561
http://dx.doi.org/10.4172/2155-6113.1000479
_version_ 1782410819796992000
author Aziz, Mariam
Mahmood, Fareeha
Mata, Mariana
Durkin, Helen G
Liu, Chenglong
Greenblatt, Ruth M
Nowicki, Marek
Golub, Elizabeth T
Anastos, Kathryn
French, Audrey L
Baum, Linda L
author_facet Aziz, Mariam
Mahmood, Fareeha
Mata, Mariana
Durkin, Helen G
Liu, Chenglong
Greenblatt, Ruth M
Nowicki, Marek
Golub, Elizabeth T
Anastos, Kathryn
French, Audrey L
Baum, Linda L
author_sort Aziz, Mariam
collection PubMed
description BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre- to 6 year post-seroconversion using a (51)Cr-release assay to measure HIV-1 gp120 specific ADCC. RESULTS: No SC had significant HIV specific CVL ADCC activity before seroconversion or until 1.5 yr after seroconversion. One individual had a %Specific Release (SR) of 25.4 at 2 years, 26.7 at 3 years and 21.0 at 4 years after seroconversion in CVL. Another sample had 4.7% SR at 2 years, 5.3 at 3 years, 10.9 at 4 years, and 8.4 at 5 years after seroconversion in CVL. A third had no activity until 17% SR 5 years after seroconversion in CVL. A fourth showed activity of 36.5% SR at 6.5 years after seroconversion. Seven women had no ADCC activity in their CVL. Paired serum samples showed HIV specific ADCC activity prior to the appearance of CVL ADCC activity. CONCLUSIONS: HIV specific ADCC activity in CVL rose 2 years after seroconversion; ADCC was present in the serum prior to this time. These data suggest that genital tract ADCC activity is not present until well after acute infection.
format Online
Article
Text
id pubmed-4718584
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-47185842016-01-19 Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters Aziz, Mariam Mahmood, Fareeha Mata, Mariana Durkin, Helen G Liu, Chenglong Greenblatt, Ruth M Nowicki, Marek Golub, Elizabeth T Anastos, Kathryn French, Audrey L Baum, Linda L J AIDS Clin Res Article BACKGROUND: We measured antibody-dependent cell mediated cytotoxicity (ADCC) activity in serum and genital fluids of heterosexually exposed women during HIV seroconversion. METHODS: Plasma and cervico-vaginal lavage (CVL) fluid from 11 seroconverters (SC) were analyzed biannually from one year pre- to 6 year post-seroconversion using a (51)Cr-release assay to measure HIV-1 gp120 specific ADCC. RESULTS: No SC had significant HIV specific CVL ADCC activity before seroconversion or until 1.5 yr after seroconversion. One individual had a %Specific Release (SR) of 25.4 at 2 years, 26.7 at 3 years and 21.0 at 4 years after seroconversion in CVL. Another sample had 4.7% SR at 2 years, 5.3 at 3 years, 10.9 at 4 years, and 8.4 at 5 years after seroconversion in CVL. A third had no activity until 17% SR 5 years after seroconversion in CVL. A fourth showed activity of 36.5% SR at 6.5 years after seroconversion. Seven women had no ADCC activity in their CVL. Paired serum samples showed HIV specific ADCC activity prior to the appearance of CVL ADCC activity. CONCLUSIONS: HIV specific ADCC activity in CVL rose 2 years after seroconversion; ADCC was present in the serum prior to this time. These data suggest that genital tract ADCC activity is not present until well after acute infection. 2015-07-09 2015-07 /pmc/articles/PMC4718584/ /pubmed/26798561 http://dx.doi.org/10.4172/2155-6113.1000479 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Aziz, Mariam
Mahmood, Fareeha
Mata, Mariana
Durkin, Helen G
Liu, Chenglong
Greenblatt, Ruth M
Nowicki, Marek
Golub, Elizabeth T
Anastos, Kathryn
French, Audrey L
Baum, Linda L
Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title_full Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title_fullStr Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title_full_unstemmed Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title_short Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
title_sort development of igg mediated antibody dependent cell-mediated cytotoxicity (adcc) in the serum and genital mucosa of hiv seroconverters
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718584/
https://www.ncbi.nlm.nih.gov/pubmed/26798561
http://dx.doi.org/10.4172/2155-6113.1000479
work_keys_str_mv AT azizmariam developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT mahmoodfareeha developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT matamariana developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT durkinheleng developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT liuchenglong developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT greenblattruthm developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT nowickimarek developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT golubelizabetht developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT anastoskathryn developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT frenchaudreyl developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters
AT baumlindal developmentofiggmediatedantibodydependentcellmediatedcytotoxicityadccintheserumandgenitalmucosaofhivseroconverters